takeaways on the management of early-stage tnbc
Published 1 year ago • 204 plays • Length 1:29Download video MP4
Download video MP3
Similar videos
-
2:46
de-escalation of therapy in early-stage tnbc
-
29:20
educational sessions: "optimizing the management of early stage tnbc"
-
5:53
treating early-stage tnbc
-
2:21
the challenges of treating early-stage tnbc
-
0:58
personalizing approaches in early-stage tnbc
-
2:14
clinical and molecular characteristics of her2-low/zero early stage triple-negative breast cancer
-
1:27
what to do in patients with early-stage tnbc who have not achieved a pcr?
-
1:34
strategies to improve the response to immunotherapy in tnbc
-
59:23
optimizing the management of early-stage tnbc: symptoms, treatments, and recurrence
-
1:41
personalized medicine in early-stage tnbc
-
3:09
keynote-522: neoadjuvant and adjuvant pembrolizumab for early tnbc
-
4:33
management of triple-negative breast cancer
-
4:20
keynote-522: 5-year follow-up of pembrolizumab in triple-negative breast cancer
-
7:36
esmo 2020 expert video report on atezolizumab in upfront treatment of tnbc
-
2:39
the role of biomarkers in guiding treatment for early-stage breast cancer
-
1:14
the importance of a biomarker-directed approach in triple-negative breast cancer
-
5:21
optimal neoadjuvant and adjuvant therapy for patients with early tnbc
-
3:28
immunotherapy in early-stage tnbc - where do we stand?
-
21:36
treatment planning for triple negative breast cancer | 2022 evolution conference